Table 4.
Correlation analysis between survivor subgroups and median allele frequency rates of pathogenic KRAS and TP53 mutations. A Mann–Whitney U test was used to test for significance (p-value < 0.05 indicates significance).
| OS | OS | DFS | DFS | |||
|---|---|---|---|---|---|---|
| <4 Years | ≥4 Years | p-Value | <2 Years | ≥2 Years | p-Value | |
| n = 31 | n = 8 | n = 32 | n = 7 | |||
|
Median (range)
allele frequency rate KRAS |
14% (2–32%) |
11% (4–30%) |
0.368 | 14.5% (2–32%) |
11.0% (4–13%) |
0.042 |
|
Median (range)
allele frequency rate TP53 |
17% (10–54%) |
11% (2–17%) |
0.017 | 17% (2–54%) |
12% (10–14%) |
0.054 |
DFS: disease-free survival; OS: overall survival.